BioCity Nottingham, Pennyfoot Street, Nottingham, NG1 1GF
t: +44 (0) 115 8880 406f: +44 (0) 115 8229345

News Articles

Novartis decision completes a new model for SPCs in EU

17 April 2012

SCRIP Regulatory Affairs April 2012, 5
Authors: Mike Snodin and Michael Pears

This article appeared in the April 2012 edition of SCRIP Regulatory Affairs. It reports the decision in the Novartis v Actavis case at the CJEU (case C-442/11) and explains its significance and practical consequences.

We have placed cookies on your device to help make this website better. You can click the link below to disable cookies, otherwise, we'll assume you're happy to continue
Close This Notice

Disable Cookies | 3rd Party Data Processors